🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a randomized, controlled, open-label, multicenter trial. Pati...
Status
Recruiting
Location
The First Affiliated Hospital of Air Force Military Medical University
Start Date
2026-08-10
Trial ID
NCT07751302
Treatments Being Tested
Gastric cancer is a highly heterogeneous tumor. The most commonly used clin...
Status
Withdrawn
Location
Beijing Cancer Hospital / Peking University Cancer Hospital
Start Date
2021-05-11
Trial ID
NCT04863430
Treatments Being Tested
This is a randomized, controlled, multi-center, open trial, unresectable lo...
Status
Recruiting
Location
Chinese PLA General Hospital
Start Date
2021-01-21
Trial ID
NCT04415853
Treatments Being Tested
This is a non-randomized, phase II, open label study of apatinib mesylate t...
Status
Completed
Location
Shanghai ninth people's hospital
Start Date
2017-10-01
Trial ID
NCT03267121
Treatments Being Tested
To evaluate the efficacy and safety of Sintilimab combined with apatinib an...
Status
Unknown
Location
Affiliated Hospital of Qinghai University
Start Date
2022-02-15
Trial ID
NCT05216237
Treatments Being Tested
Based on the FRECO-2 study, Fruquintinib has become one of the standard thi...
Status
Unknown
Location
Sichuan University West China Hospital
Start Date
2023-02-20
Trial ID
NCT06427005
Treatments Being Tested
This Phase II trial evaluates the efficacy and safety of Serplulimab combin...
Status
Unknown
Location
Zhejiang Cancer Hospital
Start Date
2024-05-20
Trial ID
NCT06422858
Treatments Being Tested
This is a non-randomized, phase II, open label study of apatinib mesylate t...
Status
Unknown
Location
Shanghai ninth people's hospital
Start Date
2016-12-23
Trial ID
NCT03096184
Treatments Being Tested
This study is a phase II, prospective, single-center, single-arm trial to e...
Status
Unknown
Location
ZhongShan hospital Fudan university
Start Date
2021-12-30
Trial ID
NCT04799548
Treatments Being Tested
This study plans to enroll participants with previously treated metastatic ...
Status
Recruiting
Location
Peking University Cancer Hospital & Institute
Start Date
2025-12-04
Trial ID
NCT07262567
Treatments Being Tested